Skip to content

Evaluation of the Effectiveness of the Artificial Intelligence-Based Diabetes Management Model in Real-word setting

Evaluation of the Effectiveness of the Artificial Intelligence-Based Diabetes Management Model in Real-word setting

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114588
Enrollment
Unknown
Registered
2025-12-15
Start date
2025-12-15
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Observation group:None

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 years and above; 2.Diagnosed with Type 2 diabetes; 3.Proficiency in operating a smartphone; 4.Voluntarily signed the informed consent form;

Exclusion criteria

Exclusion criteria: 1.Other forms of diabetes mellitus, such as type 1 diabetes and gestational diabetes mellitus; 2.having severe comorbidities related to diabetes; 3.Uncontrolled chronic liver diseases, such as hemochromatosis, hepatocellular carcinoma, autoimmune liver disease, liver cirrhosis, viral hepatitis (including hepatitis A, B, and C), or Wilson's disease. 4.History of psychiatric disorders, such as schizophrenia, depression, or bipolar disorder. 5.History of substance abuse within the 3 months before screening. 6.Currently receiving therapy with medications that influence glucose metabolism, including corticosteroids, immunosuppressive agents, or weight-loss drugs. 7.Pregnancy, lactation, or plans to become pregnant.

Design outcomes

Primary

MeasureTime frame
TAR(Time Above Rang);Proportion of patients achieving the 2-hour postprandial blood glucose target;TBR(Time Below Range);Proportion of patients achieving the fasting blood glucose target;BMI;TIR(Time In Range);Coefficient of Variation for Blood Glucose;

Secondary

MeasureTime frame
Dosage of oral antidiabetic medications and insulin;Hypoglycemic episode;Height;Body Weight;

Countries

China

Contacts

Public ContactChenglin Sun

The First Hospital of Jilin University

clsun213@163.com+86 431 88782886

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026